2 most recent filings and news items mentioning EWTX. Updated every 60 seconds.
M&AJun 1, 2026Positive
Edgewise Therapeutics agreed to sell its sevasemten asset and muscular dystrophy business to Servier for $1.55 billion upfront plus up to $1.1 billion in milestone payments. The transaction allows Edgewise to strengthen its balance sheet and refocus on its cardiovascular pipeline
View filing at SEC.gov →
RegulatoryMay 20, 2026Neutral
Euronet Worldwide submitted an exhibit filing with the Securities and Exchange Commission. The filing appears to be a standard regulatory disclosure requirement for publicly traded companies.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.